Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705809 · ClinicalTrials.gov registry record
T-Cell Project: Epidemiologic Component
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 800
- Enrollment target
NCT00705809: Completed study, sponsored by National Cancer Institute (NCI).
NCT00705809 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00705809 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
Background: * The T-Cell Project, sponsored by the International T-cell non-Hodgkin Lymphoma Study Group, is a consortium of institutions interested in achieving more detailed information on clinical and biological characteristics of T-cell lymphomas. * The T-Cell Project serves as a repository for data on patients with peripheral T-cell lymphoma (PTCL) worldwide. Its overall goal is to improve T-cell subtype classifications and evaluate treatment strategies for each subtype. Objectives: -To implement a standardized epidemiologic questionnaire into the ongoing T-Cell Project to allow evaluation of various potential risk factors for PTLCs. Eligibility: -Untreated patients 18 years of age and older who were diagnosed with PTLC September 1, 2006, or later. Design: -Patients complete a questionnaire containing the following information: Demographic information Smoking history and alcohol use Personal history or cancer History of cancer among first-degree relatives Medical history History of transplants History of blood transfusions Medication use Occupational and residential history Pesticide treatment -The information collected is linked to clinical and pathologic information in the T-Cell Project database.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2008-06-18 |
| Est. Completion | 2011-07-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00705809
The ClinicalTrials.gov registry entry for NCT00705809 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00705809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00705809 about?
NCT00705809 is a clinical study titled "T-Cell Project: Epidemiologic Component". Background: * The T-Cell Project, sponsored by the International T-cell non-Hodgkin Lymphoma Study Group, is a consortium of institutions interested in achieving more detailed information on clinical and biological characteristics of T-cell lymphomas. * The T-Cell Project serves as a repository for...
What is the current status of trial NCT00705809?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2008-06-18. Estimated completion is 2011-07-20.
Who is sponsoring clinical trial NCT00705809?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.